Bio-Techne Corp
A maker of the proteins, antibodies, and lab instruments that scientists use to study cells and diagnose disease, Bio-Techne sells brands like R&D Systems and ProteinSimple to researchers worldwide. It began in 1976 in Minneapolis as R&D Systems, making controls to verify blood-analysis machines, and rebranded as Bio-Techne in 2014 — a name blending "bio" with the Greek word "techne," meaning art or craft. Its first product, launched in 1977, was a platelet-rich-plasma control.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| FMR LLC | 13G/APassive | 8.1% | 12.75M | Aug 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 8.1% | 12.75M | Aug 6, 2026 |
| Vanguard Capital Management | 13GPassive | 7.38% | 11.56M | Apr 29, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| T. Rowe Price Associates, Inc. | 13G/APassive | 2.2% | 3.35M | Nov 14, 2025 |
| BlackRock, Inc. | 13G/APassive | 7% | 11.01M | Jul 16, 2025 |